To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbBliss Gvs Pharma Ltd Share Price
breadcrumbResults

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on June 30, 2025Data in Crores of INR
Revenue
₹ 207.47+12.97% from last year
Operating profits
₹ 76.78+99.68% from last year
Net income
₹ 44.36+100.66% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Net worth1050.38967.19883.90818.70808.25735.61646.00536.24486.62412.62
Fixed assets404.95369.37378.05280.76233.72240.97144.97136.48303.86225.25
Debt70.9787.8198.07104.96118.75120.96101.94117.95225.39131.51
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating105.91102.8234.31135.4863.9746.7039.9517.64289.47112.95
Investing -75.44-83.19-7.75-92.98-46.99-47.89-73.5250.24-231.25-49.84
Financing -30.34-20.89-24.94-23.73-20.80-6.3016.83-75.98-10.13-40.25

Financial ratios

Profitability ratiosinfo2
ROA7.18%
ROE9.01%
ROCE12.29%
EPS8%
Net profit margin11.15%
Operating profit margin20.15%
Dividend per share0.5%
Operational ratiosinfo2
Quick ratio4.04%
Current ratio4.77%
Interest coverage16.47%
Assets turnover0.64%
Debt to equity0.07%
Valuation ratiosinfo2
P/E ratio18.22%
P/B ratio1.79%
Dividend yield0.27%
EV/EBITDA
Bliss GVS Pharma Limited is a fast-growing Pharmaceutical Company with a proven track record of developing manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. It is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. Over the last decade it has acquired definitive know-how in other dosage forms & therapeutic segments which is exemplified by its ever-expanding product offering across more than sixty countries. With significant expansion in R & D Manufacturing & Marketing capabilities it is poised for an accelerated rate of growth which makes for very exciting times at Bliss GVS.
personal

Grow your wealth with more research recommendations

+91